Behavioral Programs for Diabetes Mellitus

53. Medical Advisory Secretariat. Behavioural
interventions for type 2 diabetes: an
evidence-based analysis. Ont Health
Technol Assess Ser. 2009;9(21):1-45.
PMID: 23074526.
54. Ellis SE, Speroff T, Dittus RS, et al.
Diabetes patient education: a meta-analysis
and meta-regression. Patient Educ Couns.
2004 Jan;52(1):97-105. PMID: 14729296.
55. Glazier RH, Bajcar J, Kennie NR, et al. A
systematic review of interventions to
improve diabetes care in socially
disadvantaged populations. Diabetes Care.
2006 Jul;29(7):1675-88. PMID: 16801602.
56. Michie S, Ashford S, Sniehotta FF, et al. A
refined taxonomy of behaviour change
techniques to help people change their
physical activity and healthy eating
behaviours: the CALO-RE taxonomy.
Psychol Health. 2011 Nov;26(11):1479-98.
PMID: 21678185.
57. Public Health Agency of Canada. Glossary
of terms. Public Health Agency of Canada;
2010. www.phac-aspc.gc.ca/php-psp/ccphcesp/glos-eng.php.
Accessed November 15,
2013.
58. Piette JD. Interactive behavior change
technology to support diabetes selfmanagement:
where do we stand? Diabetes
Care. 2007 Oct;30(10):2425-32. PMID:
17586735.
59. Agency for Healthcare Research and
Quality. Methods Guide for Effectiveness
and Comparative Effectiveness Reviews.
AHRQ publication no. 10(14)-ehc063-ef.
AHRQ; 2014.
www.effectivehealthcare.ahrq.gov.
Accessed March 4, 2014.
60. University of Alberta Evidence-Based
Practice Center. Behavioral programs for
diabetes mellitus (protocol). Rockville, MD:
Agency for Healthcare Research and Quality
Jun 2014. http://effectivehealthcare.ahrq.gov
61. Higgins JP, Green S. Section 6.4.11.1.
Search filters. The Cochrane Collaboration;
2011. http://handbook.cochrane.org.
Accessed March 4, 2014.
62. Malik K, Human Development Report 2013
Team. Human Development Report 2013.
The rise of the south: human progress in a
diverse world. N.Y., New York. United
Nations Development Programme 2013.
63. Ohkubo Y, Kishikawa H, Araki E, et al.
Intensive insulin therapy prevents the
progression of diabetic microvascular
complications in Japanese patients with noninsulin-dependent
diabetes mellitus: a
randomized prospective 6-year study.
Diabetes Res Clin Pract. 1995
May;28(2):103-17. PMID: 7587918.
64. Hartling L, Bond K, Santaguida PL, et al.
Testing a tool for the classification of study
designs in systematic reviews of
interventions and exposures showed
moderate reliability and low accuracy. J Clin
Epidemiol. 2011;64(8):861-71. PMID:
21531537.
65. Higgins JPT, Green S. Cochrane Handbook
for Systematic Reviews of Interventions.
The Cochrane Collaboration; 2009.
www.cochrane-handbook.org/. Accessed
January 5, 2015.
66. Pimouguet C, Le Goff M, Thiebaut R, et al.
Effectiveness of disease-management
programs for improving diabetes care: a
meta-analysis. CMAJ. 2011 Feb
8;183(2):E115-27. PMID: 21149524.
67. Tricco AC, Ivers NM, Grimshaw JM, et al.
Effectiveness of quality improvement
strategies on the management of diabetes: a
systematic review and meta-analysis.
Lancet. 2012 Jun 16;379(9833):2252-61.
PMID: 22683130.
68. U.S. Department of Health and Human
Services, Food and Drug Administration,
Center for Drug Evaluation and Research.
Guidance for industry diabetes mellitus:
Developing drugs and therapeutic biologics
for treatment and prevention.2008.
http://www.fda.gov/downloads/Drugs/Guida
nces/ucm071624.pdf. Accessed May 27,
2014.
69. Higgins JP, Green S. Section 8. Assessing
risk of bias in included studies. The
Cochrane Collaboration; 2011.
http://handbook.cochrane.org. Accessed
March 4, 2014.
93